Phys Vivas · haematological
Transfusion Medicine — Viva Defence
Structured DCE viva for transfusion medicine: long-case defence of a transfusion-dependent myelodysplasia patient plus short-case anaemia discussion, covering thresholds, reactions, chelation and consent.
2 min readVerification in progress
On this page
Study tools
Target exams
FRACP DCEMRCP Part 2
Prompt
Structured DCE viva for transfusion medicine: long-case defence of a transfusion-dependent myelodysplasia patient plus short-case anaemia discussion, covering thresholds, reactions, chelation and consent.
Opening statement (SASPOP, delivered aloud)
"Mr Reid is a 74-year-old retired engineer with transfusion-dependent myelodysplastic syndrome, presenting with shortening transfusion intervals. His main problems are: progressive marrow failure with transfusion-dependent anaemia; cumulative iron exposure from over 60 lifetime units; alloimmunisation risk; and the question of whether his disease is progressing. I would like to assess his transfusion program, screen for iron overload, and revisit disease-modifying options with him." [1]
References4ShowHide
- [1]Carson JL, Guyatt G, Heddle NM, et al. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage JAMA, 2016.PMID 27732721
- [2]Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel Transfusion, 2004.PMID 15584994
- [3]Cappellini MD, Porter JB, El-Beshlawy A, et al. Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias Haematologica, 2010.PMID 19951979
- [4]Rogers DM, Crookston KP The approach to the patient who refuses blood transfusion Transfusion, 2006.PMID 16965571